Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Filippo Giovanardi
Observed names:
F. Giovanardi,
Giovanardi Filippo,
Giovanardi, Filippo
Institution:
Azienda Sanitaria Unità Locale di Reggio Emilia
Observed institutions:
Azienda Sanitaria Unità Locale di Reggio Emilia,
Italian Oncology Group of Clinical Research,
Azienda Unità Sanitaria Locale Della Romagna,
Istituto Oncologico Veneto,
Azienda Ospedaliero-Universitaria Careggi,
Ospedaliera di Piacenza,
European Institute of Oncology
show all 7
ORCID:
0000-0002-2656-757X
Observed ORCID:
0000-0002-2656-757X
OpenAlex ID:
A5017572615
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study
2018
·
P. Conte
, A. Frassoldati
, et al.
·
Annals of Oncology
·
168
PDF
Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel
2007
·
Rosalba Torrisi
, Alessandra Balduzzi
, et al.
·
Cancer Chemotherapy and Pharmacology
·
96
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study
2019
·
M.E. Cazzaniga
, G. Pinotti
, et al.
·
The Breast
·
60
Results of the observational prospective RealFLOT study
2021
·
Elisa Giommoni
, Daniele Lavacchi
, et al.
·
BMC Cancer
·
52
PDF
Initial Panitumumab Plus Fluorouracil, Leucovorin, and Oxaliplatin or Plus Fluorouracil and Leucovorin in Elderly Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The PANDA Trial by the GONO Foundation
2023
·
Sara Lonardi
, Cosimo Rasola
, et al.
·
Journal of Clinical Oncology
·
48
PDF
Pleural Malignant Solitary Fibrous Tumor With Sarcomatous Overgrowth Showing PDGFR β Mutation
2006
·
Giulio Rossi
, Laura Schirosi
, et al.
·
CHEST Journal
·
25
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study
2021
·
M. E. Cazzaniga
, I. Vallini
, et al.
·
Breast Cancer Research and Treatment
·
20
Bioimpedance-derived body composition parameters predict mortality and dose-limiting toxicity: the multicenter ONCO-BIVA study
2024
·
E. Cereda
, A. Casirati
, et al.
·
ESMO Open
·
17
PDF
Identifying ethical values for guiding triage decisions during the COVID-19 pandemic: an Italian ethical committee perspective using Delphi methodology
2021
·
Anita Zeneli
, Giovanni Brandi
, et al.
·
BMJ Open
·
13
PDF
The Prognostic and Predictive Role of Somatic BRCA Mutations in Ovarian Cancer: Results from a Multicenter Cohort Study
2021
·
Angela Toss
, Claudia Piombino
, et al.
·
Diagnostics
·
13
PDF
A randomized phase II trial comparing preoperative plus perioperative chemotherapy with preoperative chemotherapy in patients with locally advanced breast cancer
2006
·
Andrea Rocca
, Giulia Peruzzotti
, et al.
·
Anti-Cancer Drugs
·
11
Axillary Nodal Metastases in Italian Early Breast Cancer Patients with Positive Sentinel Lymph Node: Can Axillary Node Dissection be Avoided by using Predictive Nomograms?
2015
·
Federico Biolchini
, Massimo Vicentini
, et al.
·
Tumori Journal
·
7
Breast-cancer specific comprehensive archive of Patient-Reported Outcome Measures (PROMs) for clinical research and clinical practice in oncology: Results from the PRO4All project
2024
·
Anna Amela Valsecchi
, Filippo Giovanardi
, et al.
·
The Breast
·
6
PDF
Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patients
2023
·
B. Trevisan
, F. F. Pepe
, et al.
·
Scientific Reports
·
6
PDF
Increased Mean Corpuscular Volume of Red Blood Cells in Patients Treated with Capecitabine for Advanced Breast and Colon Cancer
2013
·
Laura Scarabelli
, Filippo Giovanardi
, et al.
·
Chemotherapy
·
5
Psychometric properties of patient-reported outcomes Common Terminology Criteria for adverse events (PRO-CTCAE®) in breast cancer patients: The prospective observational multicenter VIP study
2024
·
Caterina Caminiti
, Giuseppe Maglietta
, et al.
·
The Breast
·
4
PDF
Survival Outcomes of Luminal Metastatic Breast Cancer Patients According to Changes in Molecular Subtype at Re-Biopsy: Insights from the GIM-13—AMBRA Study
2025
·
Marina Elena Cazzaniga
, Paolo Pronzato
, et al.
·
Cancers
·
3
PDF
Adjuvant endocrine therapy choices in premenopausal patients with hormone receptor-positive early breast cancer: Insights from the prospective GIM23-POSTER study
2024
·
Luca Arecco
, Maria Maddalena Latocca
, et al.
·
The Breast
·
3
PDF
Sexual dysfunction after cancer: gender differences, tumor-specific patterns, and implications for sexual medicine practice
2026
·
Isabella Bisceglia
, Fortunato Morabito
, et al.
·
Oncology Reviews
·
2
PDF
MA14.13 Analysis of Lung Cancer-Specific Patient-Reported Outcome Measures (PROMs): Results from the PRO4All Project
2024
·
A. Servetto
, F. Malandrini
, et al.
·
Journal of Thoracic Oncology
·
2
PDF
Systemic inflammatory markers in neoadjuvant pembrolizumab therapy for triple-negative breast cancer: Prognostic insights and nomogram construction.
2024
·
Filippo Giovanardi
, Chiara Casartelli
, et al.
·
Journal of Clinical Oncology
·
2
Clinical Outcomes of HER2-Negative Metastatic Breast Cancer Patients in Italy in the Last Decade: Results of the GIM 13-AMBRA Study
2023
·
Marina Elena Cazzaniga
, Paolo Pronzato
, et al.
·
Cancers
·
2
PDF
Po64 Metronomic Chemotherapy (cht) Combination of Vinorelbine (vrl) and Capecitabine (cape) in Her2- Advanced Breast Cancer (abc) Patients (pts) Does Not Impair Global Qol. First Results of the Victor-2 Study
2015
·
Marina Elena Cazzaniga
, Valter Torri
, et al.
·
The Breast
·
2
Italian prospective observational RealFLOT study: Four-year update.
2026
·
Irene Valle
, Elisa Giommoni
, et al.
·
Journal of Clinical Oncology
·
1
Trends in Survival and Mortality of “Early” Metastatic Breast Cancer in Northern Italy Following the Introduction of Targeted Therapies
2025
·
Francesco Marinelli
, Maria Barbara Braghiroli
, et al.
·
Cancers
·
1
PDF
Show more works
View as search
Works count:
68
Citation count:
594
H-index:
11
I10-index:
12
Year
Topic
Type